GENETHON

Acronym	Definition
GENETHON	Human Genome Research Centre (French)

Suggest new definition

References in periodicals archive ?

* Researchers at Whitehead and Genethon publish a physical map of the human genome containing 15,000 markers.

What is on the molecular diagnostics horizon? Part 5b--a brief history of medical diagnosis and the birth of the clinical laboratory

FRENCH RSVP...Human genome researchers worldwide are singing the praises of the multimillion dollar Genethon facilities which house the latest in robotic and gene-mapping technology.

Newstrack

Prior to joining Audentes, Mavilio served as scientific director of Genethon, Evry, France (2012-2017).

Audentes Therapeutics Names Mavilio as VP Scientific Affairs, Europe

[USPRwire, Thu Apr 09 2015] Global Markets Direct's, 'Genethon - Product Pipeline Review - 2015', provides an overview of the Genethon's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Genethon's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

New Market Research Report: Genethon - Product Pipeline Review - 2015

[ClickPress, Mon Aug 11 2014] Global Markets Direct's, 'Genethon - Product Pipeline Review - 2014', provides an overview of the Genethon's pharmaceutical research and development focus.

Genethon - Product Pipeline Review - 2014 - New Market Study Published

Most recently Dr Masquelier served as general manager of Genethon, president of GenoSafe, president of Aster-Cephac and general manager of Southern Europe for MDS Pharma Services.

Cegedim Strategic Data names Dr Anne-Marie Masquelier as global medical research director

Some of the leading companies active in this enterprising development are Alnylam Pharmaceuticals Inc, Amarna Therapeutics BV, Bayer AG, Bioverativ Inc, Catalyst Biosciences Inc, China Biologic Products Inc, CSL Ltd, Dimension Therapeutics Inc, Genethon SA and Green Cross Corp.

Hemophilia B Market: In-Depth Review of Drug Research Pipeline & Companies for the First Half of 2017

- Dr Didier Caizergues, Head of regulatory Affairs Department, International Regulatory Affairs department, GENETHON

The Real Story About Rare and Ultra-Rare Disease from the Ultra Rare Diseases, Disorder & Disabilities Foundation